First-line single-agent cetuximab in patients with advanced colorectal cancer
Pessino, A., Artale, S., Sciallero, S., Guglielmi, A., Fornarini, G., Andreotti, I.C., Mammoliti, S., Comandini, D., Caprioni, F., Bennicelli, E., Andretta, V., Siena, S., Sobrero, A.
Published in Annals of oncology (01.04.2008)
Published in Annals of oncology (01.04.2008)
Get full text
Journal Article
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies
Mammoliti, S., Andretta, V., Bennicelli, E., Caprioni, F., Comandini, D., Fornarini, G., Guglielmi, A., Pessino, A., Sciallero, S., Sobrero, A.F., Mazzola, G., Lambiase, A., Bordignon, C.
Published in Annals of oncology (01.04.2011)
Published in Annals of oncology (01.04.2011)
Get full text
Journal Article
6066 Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard regimens
Sobrero, A.F, Pessino, A, Andretta, V, Bennicelli, E, Fornarini, G, Caprioni, F, Comandini, D, Orsino, L, Lambiase, A, Bordignon, C
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
6075 A triple combination of Imatinib, Bevacizumab and Cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer
Pessino, A, Andretta, V, Guglielmi, A, Mammoliti, S, Caprioni, F, Fornarini, G, Comandini, D, Sciallero, S, Ansaldi, F, Sobrero, A
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state
Pastorino, A., Puccini, A., Martelli, V., Grassi, M., Cremante, M., Gandini, A., Puglisi, S., Catalano, F., Murianni, V., Pessino, A., Andretta, V., Mammoliti, S., Sciallero, M.S., Comandini, D., Fornarini, G., Caprioni, F., Bregni, G., Barni, S., Labianca, R., Sobrero, A.F.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
An Italian cost-effectiveness analysis of paclitaxel albumin (nab®-paclitaxel) + gemcitabine vs gemcibatine alone for metastatic pancreatic cancer patients: The APICE study
Lazzaro, C., Barone, C., Caprioni, F., Cascinu, S., Falcone, A., Maiello, E., Milella, M., Pinto, C., Reni, M., Tortora, G.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
An Italian Cost-Effectiveness Analysis of Paclitaxel Albumin (nab®-paclitaxel) + Gemcitabine vs Gemcibatine alone for Metastatic Pancreatic Cancer Patients: The APICE Study
Lazzaro, C., Barone, C., Caprioni, F., Cascinu, S., Falcone, A., Maiello, E., Milella, M., Pinto, C., Reni, M., Tortora, G.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), administered as single agent in patients (pts) with colorectal cancer (CRC) refractory to standard regimens
Rimassa, L., Sobrero, A. F., Santoro, A., Andretta, V., Gregorc, V., Sclafani, F., Caprioni, F., Caligaris-Cappio, F., Lambiase, A., Bordignon, C.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Phase II trial of imatinib, bevacizumab and cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer
Sobrero, A. F., Bennicelli, E., Pessino, A., Guglielmi, A., Mammoliti, S., Caprioni, F., Fornarini, G., Comandini, D., Sciallero, S., Ansaldi, F.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A phase II study of NGR-hTNF, a novel vascular targeting agent (VTA), administered as single agent at low dose in patients (pts) with colorectal cancer (CRC) refractory to standard regimens
Santoro, A., Andretta, V., Gregorc, V., Rimassa, L., Bennicelli, E., Sclafani, F., Caprioni, F., Caligaris-Cappio, F., Lambiase, A., Bordignon, C.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article